![Brandon Smith](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Brandon Smith
Chief Operating Officer at
PROTHENA CORPORATION PLC
Net worth: 435 760 $ as of 29/09/2026
Profile
Brandon S.
Smith is Chief Operating Officer at Prothena Corp.
Plc since 2021.
Formerly, Mr. Smith was Chief Operating Officer at Iconic Therapeutics, Inc. from 2017 to 2020, Senior VP and VP-Corporate Development & Strategy at Impax Laboratories LLC from 2012 to 2017, and Executive Director-Biosimilars Strategy at Amgen, Inc. from 2011 to 2012.
Education includes undergraduate studies at the University of Michigan and an MBA from McCombs School of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 27/07/2026 | 52,000 ( 0.1% ) | 435 760 $ | 29/09/2026 |
Brandon Smith active positions
| Companies | Position | Start |
|---|---|---|
| PROTHENA CORPORATION PLC | Chief Operating Officer | 28/09/2021 |
Former positions of Brandon Smith
| Companies | Position | End |
|---|---|---|
Iconic Therapeutics, Inc.
 Iconic Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops immunoconjugate proteins intended to translate scientific insight into breakthrough medicines for serious diseases | Chief Operating Officer | 31/12/2019 |
Impax Laboratories LLC
 Impax Laboratories LLC Pharmaceuticals: MajorHealth Technology Engages in development, manufacture and commercialization of generic and branded prescription pharmaceutical products | Corporate Officer/Principal | 31/12/2016 |
| AMGEN INC. | Corporate Officer/Principal | 31/12/2011 |
Education of Brandon Smith
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
68
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Impax Laboratories LLC
Impax Laboratories LLC Pharmaceuticals: MajorHealth Technology Engages in development, manufacture and commercialization of generic and branded prescription pharmaceutical products | Health Technology |
Iconic Therapeutics, Inc.
Iconic Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops immunoconjugate proteins intended to translate scientific insight into breakthrough medicines for serious diseases | Health Technology |
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Prothena Corp. Plc
 Prothena Corp. Plc BiotechnologyHealth Technology Focuses on the discovery and development of novel antibodies | Health Technology |
McCombs School of Business
 McCombs School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Brandon Smith
